PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 8, 2026Palliative Medicine0 citationsOpen Access

Mapping patient journeys: Exploring patient and informal carer experiences of injectable anticipatory medication care in the community to identify opportunities for practice improvements

View Full Paper
RFRosanna FennessyAPArtemis PatersonJWJames Ward

Key Points

  • The research aims to explore and map how patients and informal caregivers experience anticipatory medication care.
  • Qualitative secondary analysis of longitudinal interview data
  • Framework analysis and patient journey mapping techniques
  • Five participants analyzed from care interactions
  • Patients and informal caregivers appreciated having access to injectable medications for symptom control
  • Experiences varied significantly, often affected by context and communication challenges
  • There were gaps in information exchange concerning medication purpose and usage thresholds

Abstract

BACKGROUND: Injectable anticipatory medications are routinely prescribed ahead of need in many countries to help manage distressing end-of-life symptoms. However, little is known about the lived experience of patients and informal caregivers as they navigate their prescription, supply and use. AIM: To explore and map patient journeys in navigating anticipatory medication care, and to identify healthcare interactions with the greatest potential for enhancing patient and informal caregiver experiences of care. DESIGN: Qualitative secondary analysis of longitudinal interview data using framework analysis and patient journey mapping techniques. SETTING/PARTICIPANTS: = 5). RESULTS: Visually mapping journeys highlighted that patients and informal caregivers' experiences of anticipatory medication processes varied greatly and were influenced by the context of care. All participants appreciated access to injectable medications for future symptom control. However, journeys repeatedly highlighted suboptimal information exchange between patients, informal caregivers and healthcare professionals, regarding their purpose and threshold for use. Navigating unfamiliar and complex end-of-life medication support systems was more challenging when patients lived alone or experienced communication difficulties. CONCLUSIONS: Patient and informal caregiver experiences of timely symptom control could be improved by healthcare professionals having open and ongoing conversations about the role of anticipatory medications. Simplified and well-signposted routes for accessing healthcare professional advice and medication input are needed. Using journey mapping offers a novel way to visually illustrate different patient and informal caregivers lived experience and can be adapted for researching experiences of various care pathways.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Fennessy et al. (2026) studied this question.

synapsesocial.com/papers/69fd7e42bfa21ec5bbf06817https://doi.org/10.1177/02692163261437596
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mapping patient journeys: exploring patient and informal carer experiences of injectable anticipatory medication care in the community to identify opportunities for practice improvements2026
  2. 2Mapping patient journeys: a novel method to explore patient and carer experiences of injectable anticipatory medication care in the community and identify opportunities for improvement2025
  3. 3Administering injectable medications prescribed in the anticipation of the end of life in the community: A mixed-methods observational study2024 · 3 citations
  4. 4Accessing and administering anticipatory medications for community end-of-life symptom control: A qualitative focus group study2026
  5. 5Hidden work and blurred boundaries: A qualitative study of how community nurses navigate and adapt injectable medication processes to provide timely end- of-life symptom control2026